Company Analysis
Sign in

Foghorn Therapeutics Inc. (FHTX)

Nasdaq: FHTX · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2020
Full chart Alerts Compare
Grade4.7
◀ Past 5.3● Present 4.1▶ Future 5.0
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

17 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Foghorn Therapeutics Inc.’s names, not what it holds today.

Patents granted
17
17 utility, 1976 to Dec 31, 2025
Granted in 2025
8
Against 1 in 2024 and 5 in 2023
Applications published
55
9 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Organic fine chemistry10
Pharmaceuticals7
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Foghorn Therapeutics Inc. its own name
named as the applicant on its applications, in US
0 granted
54 published
FOGHORN THERAPEUTICS INC. its own name
US, as the owner printed on each patent
17 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 30, 202512,509,453BRM/BRG1 inhibitors and uses thereofOrganic fine chemistryFOGHORN THERAPEUTICS INC.
Dec 2, 202512,486,262Compounds and uses thereofPharmaceuticalsFOGHORN THERAPEUTICS INC.
Oct 14, 202512,441,726Compounds and uses thereofOrganic fine chemistryFOGHORN THERAPEUTICS INC.
Aug 19, 202512,391,686Compounds and uses thereofOrganic fine chemistryFOGHORN THERAPEUTICS INC.
Aug 12, 202512,384,776Compounds and uses thereofOrganic fine chemistryFOGHORN THERAPEUTICS INC.
Aug 12, 202512,383,560Compounds and uses thereofPharmaceuticalsFOGHORN THERAPEUTICS INC.
Aug 12, 202512,383,555Methods of treating cancersPharmaceuticalsFOGHORN THERAPEUTICS INC.
Jul 8, 202512,351,579Compounds and uses thereofOrganic fine chemistryFOGHORN THERAPEUTICS INC.
Nov 12, 202412,139,487Compounds and uses thereofOrganic fine chemistryFOGHORN THERAPEUTICS INC.
Dec 26, 202311,851,445Compounds and uses thereofPharmaceuticalsFOGHORN THERAPEUTICS INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 6, 20252025/0339441METHODS OF TREATING CANCERPharmaceuticalsFoghorn Therapeutics Inc.
Oct 23, 20252025/0325553METHODS OF TREATING CANCERPharmaceuticalsFoghorn Therapeutics Inc.
Oct 2, 20252025/0304596PYRAZINE DERIVATIVES AND USES THEREOFOrganic fine chemistryFoghorn Therapeutics Inc.
Oct 2, 20252025/0302832PYRAZINE DERIVATIVES AND USES THEREOFPharmaceuticalsFoghorn Therapeutics Inc.
Aug 14, 20252025/0255857METHODS OF TREATING ANDROGEN RECEPTOR-INDEPENDENT PROSTATE CANCERPharmaceuticalsFoghorn Therapeutics Inc.
Jul 31, 20252025/0241931METHODS OF TREATING A SUBJECT HAVING CLINICALLY SIGNIFICANT SIGNS AND SYMPTOMS ASSOCIATED WITH BLOOD CELL DIFFERENTIATIONPharmaceuticalsFoghorn Therapeutics Inc.
Jul 24, 20252025/0235432METHODS OF TREATING CANCERSPharmaceuticalsFoghorn Therapeutics Inc.
Mar 13, 20252025/0085300STABILITY-ENHANCING COMPOSITIONS AND METHODS OF PREPARING COMPOUNDSAnalysis of biological materialsFoghorn Therapeutics Inc.
Feb 27, 20252025/0066354COMPOUNDS AND USES THEREOFOrganic fine chemistryFoghorn Therapeutics Inc.
Nov 14, 20242024/0376121COMPOUNDS AND USES THEREOFPharmaceuticalsFoghorn Therapeutics Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 15 · Organic fine chemistry 7 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton FHTX · research, not advice